Differential vascular effects of aspirin in patients with type 2 diabetes without cardiovascular disease and matched controls without diabetes

被引：0
|
作者：
Vernstrom, L. [1 ]
Laugesen, E. [1 ]
Grove, E. L. [1 ]
Baier, J. M. [1 ]
Gullaksen, S. [1 ]
Hvas, A. -M. [1 ]
Poulsen, P. L. [1 ]
Funck, K. L. [1 ]
机构：
[1] Aarhus Univ Hosp, Aarhus, Denmark
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1160
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [31] Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study)
    Buscemi, Silvio
    Buscemi, Carola
    Borzi, Antonio Maria
    Cosentino, Loretta
    Rosafio, Giuseppe
    Randazzo, Cristiana
    Colomba, Daniela
    Di Raimondo, Domenico
    Pluchinotta, Francesca Romana
    Parrinello, Gaspare
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2020, 18 (02) : 110 - 118
  • [32] Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study
    Cruickshank, JM
    [J]. LANCET, 2002, 359 (9324): : 2200 - 2201
  • [33] Emerging risk factors in patients with diabetes without cardiovascular disease
    Alaveras, A
    Zisaki, A
    Kouloheri, S
    Kalofoutis, A
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 154 - 154
  • [34] THE BENEFIT OF ASPIRIN FOR PATIENTS WITHOUT CARDIOVASCULAR DISEASE
    Lu, Zhang
    Liu, Huadong
    Pang, Xinli
    Dong, Shaohong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1745 - 1745
  • [35] Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
    Baksh, Sheriza N.
    Segal, Jodi B.
    McAdams-DeMarco, Mara
    Kalyani, Rita R.
    Alexander, G. Caleb
    Ehrhardt, Stephan
    [J]. PLOS ONE, 2020, 15 (10):
  • [36] Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease
    Khripun, Irina A.
    Vorobyev, Sergey V.
    Morgunov, Maxim N.
    Kogan, Michail I.
    [J]. DIABETES MELLITUS, 2016, 19 (05): : 383 - 387
  • [37] Pro-B-Type Natriuretic Peptide Strongly Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those Without Type 2 Diabetes
    Saely, Christoph H.
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin, Daniela
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    [J]. DIABETES, 2018, 67
  • [38] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS FUTURE CARDIOVASCULAR EVENTS IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT TYPE 2 DIABETES
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Purin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E189 - E189
  • [39] Impact of cardiovascular disease on health care costs in persons with and without type 2 diabetes
    Nichols, GA
    Brown, JB
    [J]. DIABETES, 2001, 50 : A1 - A1
  • [40] The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes
    Nichols, GA
    Brown, JB
    [J]. DIABETES CARE, 2002, 25 (03) : 482 - 486
12345